Biogen Idec makes rheumatoid arthritis breakthrough
The studies, which have been published in the Journal of Immunology, advance the understanding of rheumatoid arthritis (RA) and demonstrate that inhibiting a molecule named TWEAK may provide
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical expertise, and research initiatives throughout central Pennsylvania, US.